Today: 20 March 2026
Subscribe
Browse Category

NYSE:RDS.A 30 January 2026 - 19 March 2026

Oil Prices Surge Past $112 After Iran Hits Gulf Energy Sites as $200 Calls Grow

Oil Prices Surge Past $112 After Iran Hits Gulf Energy Sites as $200 Calls Grow

Brent crude briefly hit $112.86 a barrel after Iran struck energy sites in Qatar, Saudi Arabia, and the UAE, disrupting oil and LNG supplies. QatarEnergy reported extensive missile damage at Ras Laffan, halting LNG output, while Abu Dhabi suspended gas operations at Habshan. Asian and European markets fell. European gas prices have jumped over 60% since the conflict began on Feb. 28.
19 March 2026
··
Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

European natural gas prices held near 48 euros per megawatt hour Wednesday as Shell declared force majeure on Qatari LNG cargoes, with disruptions expected to hit from April. Asia is bidding up for replacement fuel, while Brussels considers subsidies or a price cap. LNG Canada increased shipments, but analysts warn Europe’s gas storage could end March far below average if Qatari supply issues persist.
11 March 2026
·····

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop